Premature

·MeSH: Premature Birth

20 drugs in development·13 companies·1 clinical trial

Drug Pipeline by Phase

Approved(7)

Drug	Company
carboprost	ANI PHARMACEUTICALS INC (ANIP)
carboprost	DR REDDYS LABORATORIES LTD (RDY)
diphenhydramine	ACHIEVE LIFE SCIENCES, INC. (ACHV)
diphenhydramine	Miromatrix Medical Inc. (MIRO)
ganirelix	Amphastar Pharmaceuticals, Inc. (AMPH)
neoprofen	Ultragenyx Pharmaceutical Inc. (RARE)
procainamide	NEXUS BIOPHARMA INC (NEXS)

Phase 3(2)

Drug	Company
Azithromycin	INSMED Inc (INSM)
Erythromycin	INSMED Inc (INSM)

Phase 1(1)

Drug	Company
VERVE-102	Travere Therapeutics, Inc. (TVTX)

Unknown(1)

Drug	Company
Alova	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

N/A(4)

Drug	Company
Hyaluronic acid	Revance Therapeutics, Inc. (RVNC)
Immediate Oxytocin Induction	ENANTA PHARMACEUTICALS INC (ENTA)
OvaStem™	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
Sequential Induction	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1/Phase 2(1)

Drug	Company
yt023	HWH International Inc. (HWH)

Phase 4(4)

Drug	Company
25 units botox	Revance Therapeutics, Inc. (RVNC)
50 units Botox	Revance Therapeutics, Inc. (RVNC)
75 units Botox	Revance Therapeutics, Inc. (RVNC)
BoNT-A	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 20 drugs in development for Premature across 13 companies.

There are 1 clinical trial targeting Premature tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.